[1]
Chrousos, G.P. Stress and disorders of the stress system. Nat. Rev. Endocrinol., 2009, 5(7), 374-381.
[2]
Chrousos, G.P.; Gold, P.W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA, 1992, 267(9), 1244-1252.
[3]
Elenkov, I.J.; Chrousos, G.P. Stress system : Organization, physiology and immunoregulation. Neuroimmunomodulation, 2006, 13(5-6), 257-267.
[4]
Agorastos, A.; Chrousos, G.P. The neuroendocrinology of stress: The stress-related continuum of chronic disease development. Mol. Psychiatry, 2022, 27(1), 502-513.
[5]
Chrousos, G.P.; Charmandari, E.; Kino, T. Glucocorticoid action networks : An introduction to systems biology. J. Clin. Endocrinol. Metab., 2004, 89(2), 563-564.
[6]
McEwen, B.S. Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiol. Rev., 2007, 87(3), 873-904.
[7]
McEwen, B.S. Protective and damaging effects of stress mediators. N. Engl. J. Med., 1998, 338(3), 171-179.
[8]
Agorastos, A.; Pervanidou, P.; Chrousos, G.P.; Baker, D.G. Developmental trajectories of early life stress and trauma: A narrative review on neurobiological aspects beyond stress system dysregulation. Front. Psychiatry, 2019, 10, 118.
[9]
Agorastos, A.; Pervanidou, P.; Chrousos, G.P.; Kolaitis, G. Early life stress and trauma: Developmental neuroendocrine aspects of prolonged stress system dysregulation. Hormones, 2018, 17(4), 507-520.
[10]
Heim, C.; Nemeroff, C.B. The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders. Biol. Psychiatry, 1999, 46(11), 1509-1522.
[11]
Nemeroff, C.B. Neurobiological consequences of childhood trauma. J. Clin. Psychiatry, 2004, 65(1), 18-28.
[12]
Lupien, S.J.; McEwen, B.S.; Gunnar, M.R.; Heim, C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. Neurosci., 2009, 10(6), 434-445.
[13]
Gilbert, R.; Widom, C.S.; Browne, K.; Fergusson, D.; Webb, E.; Janson, S. Burden and consequences of child maltreatment in high-income countries. Lancet, 2009, 373(9657), 68-81.
[14]
Goodwin, R.D.; Stein, M.B. Association between childhood trauma and physical disorders among adults in the United States. Psychol. Med., 2004, 34(3), 509-520.
[15]
Shonkoff, J.P.; Boyce, W.T.; McEwen, B.S. Neuroscience, molecular biology, and the childhood roots of health disparities: Building a new framework for health promotion and disease prevention. JAMA, 2009, 301(21), 2252-2259.
[16]
Chrousos, G.P.; Kino, T. Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders. Ann. N. Y. Acad. Sci., 2009, 1179, 153-166.
[17]
Raison, C.L.; Miller, A.H. When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry, 2003, 160(9), 1554-1565.
[18]
Cohen, S.; Janicki-Deverts, D.; Miller, G.E. Psychological stress and disease. JAMA, 2007, 298(14), 1685-1687.
[19]
Liu, Y.Z.; Wang, Y.X.; Jiang, C.L. Inflammation: The common pathway of stress-related diseases. Front. Hum. Neurosci., 2017, 11, 316.
[20]
Rohleder, N. Stress and inflammation : The need to address the gap in the transition between acute and chronic stress effects. Psychoneuroendocrinology, 2019, 105, 164-171.
[21]
Nicolaides, N.C.; Kanaka-Gantenbein, C.; Pervanidou, P. Developmental neuroendocrinology of early-life stress: Impact on child development and behavior. Curr. Neuropharmacol., 2024, 22(3), 461-474.
[22]
Filetti, C.; Kane-Grade, F.; Gunnar, M. The development of stress reactivity and regulation in children and adolescents. Curr. Neuropharmacol., 2024, 22(3), 395-419.
[23]
Xenaki, L.A.; Dimitrakopoulos, S.; Selakovic, M.; Stefanis, N. Stress, environment and early psychosis. Curr. Neuropharmacol., 2024, 22(3), 437-460.
[24]
Cullen, A.E.; Labad, J.; Oliver, D.; Al-Diwani, A.; Minichino, A.; Fusar-Poli, P. The translational future of stress neurobiology and psychosis vulnerability: A review of the evidence. Curr. Neuropharmacol., 2024, 22(3), 350-377.
[25]
Hodes, G.E.; Bangasser, D.; Sotiropoulos, I.; Kokras, N.; Dalla, C. Sex differences in stress response: Classical mechanisms and beyond. Curr. Neuropharmacol., 2024, 22(3), 475-494.
[26]
Kulakova, E.; Graumann, L.; Wingenfeld, K. The hypothalamus-pituitary-adrenal axis and social cognition in borderline personality disorder. Curr. Neuropharmacol., 2024, 22(3), 378-394.
Related Journals
Current Drug Safety
Current Pharmaceutical Design
Current Neurovascular Research
Current Pharmaceutical Analysis
Central Nervous System Agents in Medicinal Chemistry
Current Vascular Pharmacology
Current Alzheimer Research
CNS & Neurological Disorders - Drug Targets
Current Molecular Pharmacology
Current Aging Science
Related Books
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
New Findings from Natural Substances
Pharmaceutical Chemistry and Production: An Introductory Textbook
Evidence-Based Research in Ayurveda against COVID-19 in Compliance with Standardized Protocols and Practices
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Pharmaceuticals for Targeting Coronaviruses
Medical Applications of Beta-Glucan
Nanotechnology Driven Herbal Medicine for Burns: From Concept to Application
Frontiers in Clinical Drug Research-Dementia
